Prevalence of diabetes and frequency of glycated haemoglobin monitoring in Extremadura (Spain) during 2012, 2013 and 2014: An observational study.

Barquilla García, Alfonso; Sánchez Vega, Javier; Romero Vigara, Juan Carlos; Fernández, Leandro; Gamero Samino, María José; Buitrago, Francisco · Prim Care Diabetes · 2019

retrospective_cohort · Level III

Where this comes from

Abstract

To analyze the prevalence of diabetes and the frequency of haemoglobin A<sub>1C</sub> (HbA<sub>1C</sub>) monitoring in the population with diabetes in Extremadura (Spain). Observational, longitudinal retrospective study in the population attended in the Extremadura Health System in 2012-2014. A total of 403,644 glycated haemoglobin determinations in 189,466 subjects (52.4% female) were studied. All patients with a prescription of antidiabetic drugs and those who, despite not having treatment, had any determination of HbA<sub>1C</sub> ≥6.5% were considered as people with diabetes. All patients without treatment but with HbA<sub>1C</sub> ≥5.7% and <6.5% were considered prediabetes patients. The prevalence rate of diabetes was 8.3% and the frequency of HbA<sub>1C</sub> monitoring was 0.9/patient/year in the diabetic population. 48.2% of the patients with monitoring of HbA<sub>1C</sub> had diabetes, 21.2% had prediabetes, and 30.6% did not meet the criteria for diabetes or prediabetes. 12.7% of people with diabetes did not have determinations of HbA<sub>1C</sub> and only 11.8% have had ≥6 determinations in the period analyzed. The frequency of HbA<sub>1C</sub> monitoring in the diabetic population is lower than that usually recommended. Moreover, there is an inadequate use of HbA<sub>1C</sub> determinations, since one out of every 3 patients does not meet the criteria for diabetes or prediabetes.

Medical subject headings